These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 22198566)

  • 21. Endometrial carcinoma: a review of chemotherapy, drug resistance, and the search for new agents.
    Moxley KM; McMeekin DS
    Oncologist; 2010; 15(10):1026-33. PubMed ID: 20930101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular therapy as a future strategy in endometrial cancer.
    Thanapprapasr D; Thanapprapasr K
    Asian Pac J Cancer Prev; 2013; 14(6):3419-23. PubMed ID: 23886121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant chemotherapy for endometrial cancer: unproven.
    Creutzberg CL
    Int J Gynecol Cancer; 2010 Oct; 20(11 Suppl 2):S60-3. PubMed ID: 20975364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging drugs for endometrial cancer.
    Amadio G; Masciullo V; Ferrandina MG; Scambia G
    Expert Opin Emerg Drugs; 2014 Dec; 19(4):497-509. PubMed ID: 25330855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic therapy in metastatic or recurrent endometrial cancer.
    Pectasides D; Pectasides E; Economopoulos T
    Cancer Treat Rev; 2007 Apr; 33(2):177-90. PubMed ID: 17196749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management Strategies for Recurrent Endometrial Cancer.
    Connor EV; Rose PG
    Expert Rev Anticancer Ther; 2018 Sep; 18(9):873-885. PubMed ID: 29972650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is the role of chemotherapy in endometrial cancer?
    Hogberg T
    Curr Oncol Rep; 2011 Dec; 13(6):433-41. PubMed ID: 21874283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration.
    Humber CE; Tierney JF; Symonds RP; Collingwood M; Kirwan J; Williams C; Green JA
    Ann Oncol; 2007 Mar; 18(3):409-20. PubMed ID: 17150999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Personalized care in uterine cancer.
    Iglesias DA; Bodurka DC
    Clin Adv Hematol Oncol; 2012 Dec; 10(12):797-805. PubMed ID: 23271352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular targets and targeted therapeutics in endometrial cancer.
    Weigelt B; Banerjee S
    Curr Opin Oncol; 2012 Sep; 24(5):554-63. PubMed ID: 22581357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant treatment for stage IIIC endometrial cancer: options and controversies.
    Shah PH; Kudrimoti M; Feddock J; Randall M
    Gynecol Oncol; 2011 Sep; 122(3):675-83. PubMed ID: 21664661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant Therapy in Node-Positive Endometrial Cancer: A Focus on Chemotherapy.
    Dexter J; Lips E; DiSilvestro P
    Curr Oncol Rep; 2022 Dec; 24(12):1677-1683. PubMed ID: 36417134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current treatment of metastatic endometrial cancer.
    Temkin SM; Fleming G
    Cancer Control; 2009 Jan; 16(1):38-45. PubMed ID: 19078928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic targeting of the TNF superfamily: a promising treatment for advanced endometrial adenocarcinoma.
    Thangaraju S; Subramani E; Chakravarty B; Chaudhury K
    Gynecol Oncol; 2012 Nov; 127(2):426-32. PubMed ID: 22885470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma.
    Vale CL; Tierney J; Bull SJ; Symonds PR
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD003915. PubMed ID: 22895938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting fibroblast growth factor pathways in endometrial cancer.
    Winterhoff B; Konecny GE
    Curr Probl Cancer; 2017; 41(1):37-47. PubMed ID: 28041631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant treatment of endometrial cancer today.
    Aoki Y; Kanao H; Wang X; Yunokawa M; Omatsu K; Fusegi A; Takeshima N
    Jpn J Clin Oncol; 2020 Jul; 50(7):753-765. PubMed ID: 32463094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy.
    van den Heerik ASVM; Horeweg N; de Boer SM; Bosse T; Creutzberg CL
    Int J Gynecol Cancer; 2021 Apr; 31(4):594-604. PubMed ID: 33082238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
    Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
    Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Advanced endometrial carcinoma: primary debulking surgery or neoadjuvant chemotherapy?].
    Guyon F; Stoeckle E; Thomas L; Petit A; Sire M; Floquet A
    Bull Cancer; 2012 Jan; 99(1):43-9. PubMed ID: 22198346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.